Anal canal adenocarcinoma locally treated with abdominoperineal resection after chemoradiotherapy: case report and review of literature
Multimodal treatment in anal canal adenocarcinoma
Background: Primary adenocarcinoma of the anal canal is rare, representing less than 20% of anal canal cancers. Given the limited data regarding treatment and outcomes, the management of this type of cancer is focused on a combined modality therapy involving radical surgery and neoadjuvant/adjuvant chemoradiotherapy.
Case study: A 74-year-old woman presented with pruritus and anal pain with 6 months duration. MRI showed a semi-concentric mass in anal canal posterior wall. After an incisional biopsy that revealed an adenocarcinoma, the patient underwent neoadjuvant chemoradiotherapy followed by laparoscopic abdominoperineal resection.
Conclusion: There is limited research into anal adenocarcinoma since the rarity of this condition. The prognosis of anal adenocarcinoma is poor and the management remains controversial. Therapy strategies are not well established, however, general agreement states that a combined multimodality (combination of radical surgical resection and pre or postoperative chemoradiotherapy) achieves the best outcome.
Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2019. CA: a cancer journal for clinicians, 2019. 69(1): p. 7-34.
Valvo, F., et al., Cancer of the anal region. Critical reviews in oncology/hematology, 2019. 135: p. 115-127.
Cummings, B., J. Ajani, and C. Swallow, Cancer of the anal region. Cancer: Principles & Practice of Oncology, Eighth Edition. Philadelphia, PA: Lippincott, Williams & Wilkins, 2008.
Kleihues, P. and L.H. Sobin, World Health Organization classification of tumors. Cancer, 2000. 88(12): p. 2887-2887.
Kulkarni, M.P., et al., Adenocarcinoma of the anal canal: a report of two cases with review of literature. Indian Journal of Pathology and Microbiology, 2016. 59(3): p. 404.
Sakamoto, T., et al., Adenocarcinoma arising from an anal gland - Report of a case. International journal of surgery case reports, 2014. 5(5): p. 234-236.
Anwar, S., et al., Adenocarcinoma of the anal canal–a systematic review. Colorectal Disease, 2013. 15(12): p. 1481-1488.
Welton, M., et al., Anus. AJCC cancer staging manual, 2017: p. 275.
Pandey, P., Anal anatomy and normal histology. Sexual health, 2012. 9(6): p. 513-516.
Shia, J., An update on tumors of the anal canal. Archives of Pathology and Laboratory Medicine, 2010. 134(11): p. 1601-1611.
Belkacémi, Y., et al., Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network. International Journal of Radiation Oncology* Biology* Physics, 2003. 56(5): p. 1274-1283.
Papagikos, M., et al., Chemoradiation for adenocarcinoma of the anus. International Journal of Radiation Oncology* Biology* Physics, 2003. 55(3): p. 669-678.
Márquez, M.F., et al., Adenocarcinoma del canal anal. Revisión de conjunto. Cirugía Española, 2013. 91(5): p. 281-286.
Gradishar, W.J., et al., NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Journal of the National Comprehensive Cancer Network, 2020. 18(4).
Chang, G.J., et al., A twenty-year experience with adenocarcinoma of the anal canal. Diseases of the colon & rectum, 2009. 52(8): p. 1375-1380.
Benlice, C., et al., Robotic extralevator abdominoperineal excision of perianal Paget's disease with anal adenocarcinoma: a report of two cases. Colorectal Disease, 2019. 21(6): p. 723-723.
Lee, J. and M. Corman, Recurrence of anal adenocarcinoma after local excision and adjuvant chemoradiation therapy: report of a case and review of the literature. Journal of Gastrointestinal Surgery, 2009. 13(1): p. 150-154.
Copyright (c) 2021 Acta Chirurgica Croatica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby authorize the Acta Chirurgica Croatica (ACC) to publish their work.
The authors are aware that although ACC is Open Access journal, the copyright of all material published is vested in ACC. Open access articles are freely available to read, download, and share from the time of publication under the terms of the Creative Commons License Attribution ‐ NonCommerical No Derivative (CC BY‐NC‐ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission of ACC and appropriate acknowledgment of its source. The authors permit ACC to allow third parties to copy any part of the work without asking for permission, provided that the reference to the source is given and that this is not done for commercial purposes. Except for copyright, other proprietary rights related to the work (e.g., patent or other rights to any process or procedure) shall be retained by the author. To reproduce any text, figures, tables, or illustrations from this work in future works of their own, the author must obtain written permission from ACC.
Each of the author(s) hereby also grants permission to ACC to use such author’s name and likeness in connection with any past, present or future promotional activity by ACC, including, but not limited to, promotions for upcoming issues or publications, circulation solicitations, advertising or other publications in connection with ACC. Also, each of the author(s) hereby grants permission to ACC to use the manuscript in editorial research related to the improvement of editorial conduct, decision making, and issues related to peer review.
Each of the author(s) hereby releases and shall indemnify and hold harmless ACC and its successors, assigns, licensees, officers, directors, employees, and their respective heirs and representatives from and against any and all liabilities, losses, damages and expenses arising out of any claims of any kind that may be asserted against any of them based in whole or in part on any breach of the author(s)’ representations or warranties herein or in the work or anything contained in the work, including but not limited to any claims for copyright infringement or violation of any rights of privacy or publicity.